Analysis
A fragment of a well-studied repair protein
TB-500 is a short synthetic piece of thymosin beta-4, a protein found in almost every cell that helps cells move and build new blood vessels. Most of the science concerns the full protein, not the fragment sold online. The landmark study came in 2004, when researchers showed in Nature that thymosin beta-4 helped heart muscle cells survive and migrate after a heart attack in mice (Bock-Marquette and colleagues).
In people, the full protein has been tested as eye drops for dry eye and corneal wounds and as a gel for skin ulcers, with mixed results and no approval to date. TB-500 itself has no published human trials. Its best-known real-world story is a doping case: in 2016 the Court of Arbitration for Sport banned 34 past and present Essendon AFL players for taking thymosin beta-4 during the 2012 season. It has also been detected in racehorses.
Our view. the biology of thymosin beta-4 is credible and well published, which lends TB-500 a scientific aura. But the fragment is not the protein, injected doses are guesswork, and there is no human evidence that it speeds recovery from injury.
Studies and reports cited
- Bock-Marquette I et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 2004
- CNN: Essendon players banned by the Court of Arbitration for Sport over thymosin beta-4, January 2016
Summary of published research for general information. It is not medical advice and not a recommendation to use this substance.